Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Acute Plasmodium yoelii 17XNL Infection During BCG Vaccination Limits T Cell Responses and Mycobacterial Growth Inhibition.

Tangie E. et al, (2025), Immunology

Reducing inequalities through greater diversity in clinical trials - As important for medical devices as for drugs and therapeutics.

Roope LSJ. et al, (2025), Contemp Clin Trials Commun, 45

Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCG.

Marshall JL. et al, (2025), Nat Commun, 16

Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response.

Drennan PG. et al, (2025), Lancet Microbe

Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development.

Siegal EZ. et al, (2025), NPJ Vaccines, 10

Trajectories of Interferon-Gamma Release Assay Results Over 2 Years in Independent Cohorts From China, South Africa, Tanzania, and the United States.

Chen C. et al, (2025), Chest

Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study.

Tyrer F. et al, (2025), Diabetes Obes Metab, 27, 767 - 776

Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate.

Korompis M. et al, (2025), Sci Rep, 15

Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study.

Gharibzadeh S. et al, (2025), EClinicalMedicine, 79

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis.

De Voss CJ. et al, (2025), Front Immunol, 16

MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates.

Peralta-Álvarez MP. et al, (2024), NPJ Vaccines, 9

A dose escalation study to evaluate the safety of an aerosol BCG infection in previously BCG-vaccinated healthy human UK adults

Fredsgaard-Jones T. et al, (2024), Frontiers in Immunology, 15

Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal route.

Peralta Alvarez MP. et al, (2024), Vaccine, 42

Mtb-Specific HLA-E-Restricted T Cells Are Induced during Mtb Infection but Not after BCG Administration in Non-Human Primates and Humans

Voogd L. et al, (2024), Vaccines, 12, 1129 - 1129

Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.

Taquet M. et al, (2024), Lancet Psychiatry, 11, 696 - 708

Mtb specific HLA-E restricted T cells are induced during Mtb infection but not after BCG administration in non-human primates and humans.

Voogd L. et al, (2024)

Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study - PHOSP-COVID.

Elneima O. et al, (2024), ERJ Open Res, 10

Randomized, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route.

Audran R. et al, (2024), J Infect

Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patients.

Ongarj J. et al, (2024), Tuberculosis (Edinb), 148

Long COVID and cardiovascular disease: a prospective cohort study.

Lawson CA. et al, (2024), Open Heart, 11

Load More

Include forthcoming?